TScan Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2021
Total Assets: $188.1M
Liabilities Breakdown FY2021
Total Liabilities: $27.3M
Asset Breakdown
Total Assets: $188.1M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $161.4M | 85.8% |
| Accounts Receivable | $0 | 0.0% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $11.8M | 6.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $14.9M | 7.9% |
Liabilities Breakdown
Total Liabilities: $27.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.8M | 6.5% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $25.6M | 93.5% |